Patient Power 2022 ASH Conference Report: Deep Dive into CLL Dec 14, 2022 Nicole Lamanna, MD

[lankisterguy]

ASH Conference Coverage - 2022 ASH Conference Report: Deep Dive into CLL Dec 14, 2022

Nicole Lamanna, MD Associate Clinical Professor of Medicine

patientpower.info/chronic-l...

Patient Power host Michele Nadeem-Baker is joined by Nicole Lamanna, MD, from Columbia University, to discuss all the important 2002 American Society of Hematology (ASH) Annual Meeting updates for chronic lymphocytic leukemia (CLL) patients including combination treatments, where we are with CAR T-cell therapy, and the new BTK inhibitors.

-

This video is much longer than most Patient Power episodes, but worth the time to listen to one of my favorite "explainers" - Len

[sweatbee]

Great video.

[JerrysGirl3]

Very interesting! Dr Lamanna has always been the best! Never knew however that, if I heard correctly, that Zanubrutinib has been mixed with another drug. This is the first time I've really heard Zanubrutinib mentioned in the BTK conversations !!! Thanks Len, as always 😊

Have a wonderful holiday !! ❤️❤️🎄

Kerry